anxiety drug trial

Hi guys.

You watch all our Anxiety will be gone once this trial becomes succesfull, the current capper and manipulator will be gone forever.

All good news today and possibly another 2 million dollars flowing towards BNO.

This is billion dollar market and it would be company maker for BNO if this trial is going to be succefull.

In the meantime milestone payments will keep flowing towards BNO in ever higher quantities as the trials progress.

good luck

jojo





IRONWOOD BEGINS PHASE I TRIAL OF INVESTIGATIONAL
IW-2143 ANXIETY DRUG IN US
Bionomics Limited (ASX: BNO) (ADR: BMICY) has been advised by its licensee Ironwood
Pharmaceuticals Inc (NASDAQ:IRWD) that, following the submission of an Investigational
New Drug (IND) application to the US Food and Drug Administration (FDA) last month, the
planned Phase I clinical trial of the investigational anti-anxiety drug candidate IW-2143
(BNC210) has begun in the US.
The trial is designed to assess the safety and pharmacokinetics of IW-2143 in healthy
volunteers, using single and multi-dose administration.
“This is the first US clinical trial of IW-2143 and this news is welcomed by Bionomics as a
strong signal of the progress being made by Ironwood in moving ahead with the study of IW-
2143,” said CEO and Managing Director of Bionomics Dr Deborah Rathjen. “As this trial
progresses it is anticipated that a US$2 million milestone payment to Bionomics by Ironwood
will be triggered.”
Ironwood is responsible for developing and, if approved, commercialising IW-2143 and
related compounds, including paying for the costs of clinical development.
In the US, anxiety disorders affect approximately 40 million Americans each year and while
there are therapies available, there remains significant unmet need.
FOR